Free Trial

ORIC Pharmaceuticals (ORIC) SEC Filings & 10K Form

$9.61
+0.07 (+0.73%)
(As of 10/4/2024 ET)

Recent ORIC Pharmaceuticals SEC Filings

DateFilerForm TypeView
08/12/2024
3:20 PM
ORIC Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2024
3:10 PM
ORIC Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
3:26 PM
ORIC Pharmaceuticals (Issuer)
You Angie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:21 PM
Heyman Richard A. (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:22 PM
Dier Mardi (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:24 PM
Hoerter Steven L. (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
5:48 PM
Kunkel Lori Anne (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2024
3:15 PM
ORIC Pharmaceuticals (Filer)
Form ARS
04/24/2024
3:06 PM
ORIC Pharmaceuticals (Filer)
Form DEF 14A
04/24/2024
3:10 PM
ORIC Pharmaceuticals (Filer)
Form DEFA14A
03/29/2024
3:47 PM
ORIC Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/29/2024
3:15 PM
ORIC Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2024
4:28 PM
ORIC Pharmaceuticals (Filer)
Form S-3ASR
03/11/2024
3:20 PM
ORIC Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/11/2024
7:19 AM
FMR LLC (Filed by)
ORIC Pharmaceuticals (Subject)
Form SC 13G/A
03/08/2024
3:20 PM
Chacko Jacob (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
5:19 PM
EcoR1 Capital, LLC (Filed by)
ORIC Pharmaceuticals (Subject)
Form SC 13G/A
02/13/2024
5:43 PM
ALKEON CAPITAL MANAGEMENT LLC (Filed by)
ORIC Pharmaceuticals (Subject)
Form SC 13G/A
02/13/2024
8:26 AM
ORIC Pharmaceuticals (Subject)
Prosight Management, LP (Filed by)
Form SC 13G/A
02/09/2024
8:28 AM
FMR LLC (Filed by)
ORIC Pharmaceuticals (Subject)
Form SC 13G/A
02/08/2024
7:01 PM
Chacko Jacob (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2024
4:09 PM
BlackRock Inc. (Filed by)
ORIC Pharmaceuticals (Subject)
Form SC 13G/A
02/04/2024
11:15 PM
ORIC Pharmaceuticals (Filer)
Form EFFECT
01/30/2024
11:12 AM
ORIC Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
01/29/2024
4:25 PM
BlackRock Inc. (Filed by)
ORIC Pharmaceuticals (Subject)
Form SC 13G
01/22/2024
8:01 AM
ORIC Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2024
8:00 AM
ORIC Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2023
11:15 PM
ORIC Pharmaceuticals (Filer)
Form EFFECT
12/19/2023
6:40 PM
ORIC Pharmaceuticals (Issuer)
Piscitelli Dominic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
6:42 PM
Multani Pratik S (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
6:39 PM
Chacko Jacob (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2023
3:32 PM
ORIC Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/06/2023
3:20 PM
ORIC Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2023
3:10 PM
ORIC Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2023
3:07 PM
ORIC Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ORIC) was last updated on 10/6/2024 by MarketBeat.com Staff
From Our Partners